For research, professional, and investigational evaluation only. No exosome product is FDA-approved for therapeutic use in humans.
Biological materials
Exosome materials.
Source-specific materials with lot release records for donor eligibility, sterility, endotoxin and particle characterization.
Material lines
Compare the documented specifications.
Values are transcribed from available Matrix and Alocyte release documents. Request the current lot record before relying on a value.
Matrix↗
Matrix
Amniotic-derived matrix material with source documentation linked to the released lot.
SourceAmniotic-derived
Particle concentration1.0 × 10⁹–1.0 × 10¹² / mL
Mode size50–250 nm
SterilityUSP <71> · no growth
EndotoxinUSP <85> · <5.0 EU/mL
Cell viabilityNot applicable
Alocyte↗
Alocyte
Cell- and particle-characterized material supplied with release criteria tied to its lot record.
SourceUmbilical cord blood (allogeneic)
Particle concentration3.0–5.0 × 10¹² / mL
Mode size50–200 nm
SterilityUSP <71> · no growth
EndotoxinUSP <85> · <5.0 EU/mL
Cell viability>70%
Important limitation
Specifications are not clinical claims.
Particle concentration, mode size, sterility and endotoxin results describe the tested material and its release criteria. They do not establish safety or efficacy for human use.
Documentation available
Start with the records.
Tell us which material and lot you are evaluating.